PHS
RZLT icon

PFM Health Sciences’s Rezolute RZLT Stock Holding History

PFM Health Sciences’s Portfolio RZLT Stock Details RZLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$393K Sell
128,726
-77,539
-38% -$233K 0.04% 83
2025
Q4 		$487K Sell
206,265
-246,468
-54% -$1.93M 0.05% 76
2025
Q3 		$4.26M Buy
452,733
+18,599
+4% +$124K 0.33% 55
2025
Q2 		$1.94M Buy
+434,134
New +$1.61M 0.16% 49

Other funds holding RZLT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PFM Health Sciences's RZLT Position: Q1 2026 in Review

PFM Health Sciences reduced its Rezolute (RZLT) stake by 38% in Q1 2026, selling an estimated $233K and leaving 128,726 shares worth $393K. The position accounts for 0.04% of the portfolio, ranked #83.

PFM Health Sciences first reported a position in RZLT in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.26M in Q3 2025. 124 funds tracked by Wall St. Rank hold RZLT as of Q1 2026.

  • PFM Health Sciences held 128,726 shares of Rezolute worth $393K as of Q1 2026.
  • PFM Health Sciences sold 77,539 Rezolute shares in Q1 2026, an estimated $233K.
  • Rezolute made up 0.04% of PFM Health Sciences's portfolio in Q1 2026, its #83 holding.
  • PFM Health Sciences first reported a position in Rezolute in Q2 2025 and has held it in 4 quarters since.
  • PFM Health Sciences's Rezolute position peaked at $4.26M in Q3 2025.
  • 124 funds tracked by Wall St. Rank held Rezolute as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.